Over 40 key opinion leaders are taking part in panel discussions, fireside chats, leading workshops and live innovation pitching.
Learn more about the impact of their work, their thoughts on rare disease progress, and hopes for the future of rare disease.
Head, Patient Strategies & Solutions, Janssen Pharmaceutical Companies
of Johnson and Johnson
Daniel Lewi –
Head of Business Development and Patient Advocacy, Pulse Infoframe, Co-Founder, Cure & Action for Taysachs Foundation
Rebecca Middleton –
Vice Chair, Participant Panel at Genomics England, Founder & Director Hereditary Brain Aneurysm Support
Dr Kath Bainbridge –
Head of Genomics Science and Emerging Technologies, Department for Health and Social Care
Dr Abdur Rasheed –
Director Division of Pharmacy, Services, Drug Regulatory Authority of Pakistan (DRAP)
Dr Gemma Chandratillake –
Chair, Cambridge Rare Disease Network; Education and Training Lead, NHS East Genomics
Dr Huma Cheema –
Consultant Paediatric Gastroenterology-Hepatology, Children Hospital & Institute of Child Health, Lahore